Doxorubicin and trabectedin for recurrent leiomyosarcoma - A case report

• Hlavní autoři: Gabriel Levin (Autor), Lucy Gilbert (Autor), Shuk On Annie Leung (Autor), Xing Zeng (Autor), Victoria Mandilaras (Autor), Laurence Bernard (Autor)
• Médium: Kniha
• Vydáno: Elsevier, 2024-10-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Uterine leiomyosarcoma (LMS) represents a rare yet highly aggressive tumor, comprising approximately 1% of uterine malignancies. First-line regimens involving doxorubicin or gemcitabine and docetaxel demonstrate modest response rates. Notably, the combination of doxorubicin plus trabectedin has emer...